Carbapenems: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "==Source==" to "==References== <references/>") |
Neil.m.young (talk | contribs) (Text replacement - "* " to "*") |
||
| Line 6: | Line 6: | ||
==Indications== | ==Indications== | ||
* Cephalosporin-resistant nosocomial bacteria | *Cephalosporin-resistant nosocomial bacteria | ||
* Empirical treatment of serious infections in patients who recently received other b-lactams | *Empirical treatment of serious infections in patients who recently received other b-lactams | ||
{{Template:Clinically Utilized Antibiotics}} | {{Template:Clinically Utilized Antibiotics}} | ||
Revision as of 03:26, 5 July 2016
Types
Indications
- Cephalosporin-resistant nosocomial bacteria
- Empirical treatment of serious infections in patients who recently received other b-lactams
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
See Also
References
Goodman & Gilman's Pharmacology